20% of U.S. adults suffer from chronic low back pain, and 25% experience joint disease.
Demographic and healthcare economic shifts are accelerating demand for non-opioid, technology-driven care.
Wireless neurostimulation is redefining precision and personalization in chronic pain management.
Our customizable wearable battery and controller reinforce the patient's sense of agency. A patient-centered application further enhances this by optimizing control over stimulation parameters and recharging needs.
A novel recharging system uncouples the wearable battery from the implant, enhancing flexibility and comfort. The neurostimulation device features multiple electrodes, offering greater optionality for delivering targeted therapy.
Our novel peripheral nerve stimulation therapy can be deployed in outpatient settings through a straightforward percutaneous procedure—reducing cost, risk, and recovery time.
The existing point of care framework, across both office and ambulatory surgical settings, aligns provider and patient incentives.
Wireless energy transfer and adaptive machine learning enable precise neurostimulation that simplifies workflows and consistently improves patient outcomes.
Established 510(k) pathways and mature reimbursement frameworks provide a clear route to approval and support steady, scalable adoption across care settings.
Outpatient and ASC providers gain new reimbursable procedures that broaden patient access, enhance operational efficiency, and drive meaningful margin growth.
CEO and Chairman of the Board
Seasoned MedTech leader with deep experience in global commercialization, product development, and M&A. Former CEO of Tenex Health (acquired by Trice Medical) and VP at Boston Scientific, where he helped drive over $800M in acquisition value across neurostimulation and heart-failure markets.
CFO and Board Member
Healthcare investor and operator with extensive experience in financing and scaling MedTech businesses. Former CFO and board member at Tenex Health, with $600M deployed across 70+ transactions and a strong track record in manufacturing, commercialization, and growth strategy.
Board Member
Founder and CEO of Thinktiv, a consulting firm focused on enhancing companies' identity and commercializing product innovations, contributing to over $17 billion in enterprise value creation across more than 25 industries. His experience in healthcare IT includes developing new patient engagement experiences and launching AI- and data-centric platforms.
Board Member
Founder and CEO of Tri-State Biologics, where he has launched and distributed more than 20 early-stage medical technology companies. Mr. Tave has extensive expertise in developing high-performing sales channels, managing product portfolios, and driving market share growth in the musculoskeletal market.
